California Life Sciences’ team of experienced government relations professionals located in Sacramento, Washington, D.C., and throughout California’s regional municipalities, directly engage with policymakers on issues of critical importance to our members and the continued success of California’s life sciences sector.
Latest CLS Policy and Advocacy Updates
About Our Federal and State Advocacy Teams
California Life Sciences engages on federal policy and regulatory items in accordance with the legislative priorities and recommendations of our membership including direct lobbying in Washington, D.C., position and coalition letters, comments and testimony.
The CLS Federal Legislative Committee (FLC) is the primary interface between our membership and identification of the policy items pertinent to CLS’s missions and objectives. The FLC meets monthly to discuss and develop positions and activities regarding federal legislative and regulatory issues of importance to our membership. The FLC also plays an integral role in the development of CLS’s annual federal policy, education, and advocacy agenda.
Our experienced state government relations team engages on behalf of the life sciences sector in multiple ways through strategic collaborations and direct lobbying in Sacramento to advance innovation, investment and job creation for California’s life sciences ecosystem.
In conjunction with the State Legislative Committee (SLC), we identify and develop position statements on issues of interest to CLS’ membership. This SLC group is composed of government affairs professionals at CLS member organizations.
In addition, we aim to favorably shape the policy environment for California’s life sciences industry by creating and leveraging a world class seamless advocacy, public affairs, and government relations program. The team advances a pro-innovation policy agenda, while ensuring patients have access to the right treatment at the right time.
California Life Sciences’ experienced local government relations team engages on behalf of the life sciences sector in multiple ways to advance the innovation, investment, and job creation for California’s life sciences ecosystem.
Local governmental bodies have an increasingly significant impact on the health and growth of California’s life sciences sector. To ensure our voice is heard, CLS provides representation and ensures ongoing dialogue between the industry and local elected officials and agencies throughout California.
Policy and Advocacy News
California Life Sciences Urges Congress to Support Rare Disease Patients
Oct 12, 2023
California Life Sciences (CLS) is pleased to support the Optimizing Research Progress Hope and New (ORPHAN) Cures Act, introduced by Reps. John Joyce, M.D. (R-PA) and Wiley Nickel (D-NC). The bipartisan..Read More
CLS statement following CMS announcement first drugs subject to price negotiation process
Aug 29, 2023
August 29, 2023 Today’s announcement by the Centers for Medicare and Medicaid Services is another disappointing step in the administration’s price-setting agenda which will irreversibly harm innovation. While CMS has..Read More